Outcomes and the quality of care for patients hospitalized with heart failure

International Journal for Quality in Health Care

Volumn 16, Issue 3, 2004, Pages 201-210

  Luthi, Jean Christophe ^a,b,c   Flanders, W Dana ^c   Pitts, Stephen R ^c   Burnand, Bernard ^a   McClellan, William M ^c,d  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Health Observatory   (Switzerland)

^c EMORY UNIVERSITY   (United States)

^d Georgia Medical Care Foundation   (United States)

Author keywords

Heart failure; Hospital mortality; Outcome research; Quality of health care; Readmissions

Indexed keywords

ACEBUTOLOL; ANGIOTENSIN ANTAGONIST; ATENOLOL; BENAZEPRIL; BETAXOLOL; BISOPROLOL; CANDESARTAN; CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; EPROSARTAN; ESMOLOL; FOSINOPRIL; IRBESARTAN; LISINOPRIL; LOSARTAN; METOPROLOL; NADOLOL; NEBIVOLOL; OXPRENOLOL; PERINDOPRIL; PINDOLOL; PROPRANOLOL; QUINAPRIL; RAMIPRIL; SOTALOL; TELMISARTAN; UNINDEXED DRUG; VALSARTAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCULATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DISEASE CLASSIFICATION; DRUG CONTRAINDICATION; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART VENTRICLE FUNCTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD; MORTALITY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SWITZERLAND; SYMPTOMATOLOGY; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH SERVICES RESEARCH; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HUMANS; INPATIENTS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT READMISSION; QUALITY OF HEALTH CARE; SWITZERLAND;

EID: 1242346582     PISSN: 13534505     EISSN: None     Source Type: Journal    
DOI: 10.1093/intqhc/mzh040     Document Type: Article

References (36)

1. Williams JF, Bristow MR, Fowler MB et al. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol 1995; 26: 1376-1398.
2. Cowie MR, Wood DA, Coats AJS et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 2000; 83: 505-510.
3. Bailly AS, Periat M. The cost of the small heart flow: a medico-metric approach (in French). Med Hyg 1997; 55: 1155-1159.
4. Konstam MA, Dracup, K, Baker DW et al. Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. Clinical practice guideline No. 11 (publication No. AHCPR 94-0612). Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1994.
5. Hunt SA, Baker DW, Chin MH et al. Evaluation and management of chronic heart failure in the adult: ACC/AHA Practice Guidelines. J Am Coll Cardiol 2001; 38: 2101-2113.
6. European Society of Cardiology, task force of working group on heart failure of the European society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1999; 16: 741-745.
7. Arbeitsgruppe für Herzinsuffizienz der schweizerischen Gesellschaft für Kardiologie. Recommendations for the diagnosis and treatment of chronic heart failure (in German). Bull Médecins Suisses 2002; 83: 1233-1242.
8. Adams KF, Baughman KL, Dec WG et al. Heart Failure Society of America (HFSA) Practice Guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction: pharmacological approaches. J Card Fail 1999; 5: 357-382.
9. Krumholz HM, Wang Y, Parent EM, Mockalis J, Petrillo M, Radford MJ. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med 1997; 157: 2242-2247.
10. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. The Large State Peer Review Organization Consortium. Arch Intern Med 1997; 157: 1103-1108.
11. Nohria A, Chen YT, Morton DJ, Walsh R, Vlasses PH, Krumholz HM. Quality of care for patients hospitalized with heart failure at academic medical centres. Am Heart J 1999; 137: 1028-1034.
12. Havraneck EP, Abbrams F, Stevens E, Parcker K. Determinants of mortality in elderly patients with heart failure. The role of angiotensin converting enzyme inhibitors. Arch Intern Med 1998; 158: 2024-2028.
13. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. J Am Med Assoc 1995; 273: 1450-1456.
14. Luthi JC, McClellan WM, Fitzgerald D et al., writing for the multistate collaborative congestive heart failure study group. Mortality associated to the quality of care of patients hospitalized with congestive heart failure. Intern J Qual Health Care 2002; 14: 15-24.
15. Luthi JC, Lund MJ, Sampietro-Colom L, Kleinbaum DG, Ballard DJ, McClellan WM. Readmissions and the quality of care in patients hospitalized with heart failure. Intern J Qual Health Care 2003; 15: 413-421.
16. Cleland JGF, Hubbard WN, Pittard J, Poole-Wilson PA, Sutton GC. ACE inhibitors in heart failure: what dose? Br Med J 1995; 71: 65-66.
17. Morant J. Ruppaner H. Swiss Drugs Compendium (in French). Basle, Switzerland: Document SA, 2000.
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbity index for use with ICD-9 CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
19. Kleinbaum DG. Logistic Regression: A Self Learning Text. New York: Springer-Verlag, 1994.
20. Kleinbaum DG, Kupper LL, Morgenstern H. Applied regression analysis and other multivariate methods. Belmont, CA: Duxbury Press, 1988.
21. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley-Interscience, 1989.
22. Clough JD, Engler D, Snow R, Canuto PE. Lack of relationship between the Cleveland Health Quality choice project and decrease in patient mortality in Cleveland. Am J Med Qual 2002; 17: 47-55.
23. Rosenthal GE, Shah A, Way LE, Harper DL. Variations in standardized hospital mortality rates for six common medical diagnoses: implications for profiling hospital quality. Med Care 1998; 36: 955-964.
24. Thomas JW, Holloway JJ. Investigating early readmission as an indicator for quality of care studies. Med Care 1991; 29: 377-394.
25. Krumholz HM, Parent EM, Qu N et al. Readmission of the hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997; 157: 99-104.
26. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multi-disciplinary intervention to prevent the readmission of early patient to risk congestive heart failure. N Engl J Med 1995; 333: 1190-1195.
27. McGrae McDermott M, Feinglass J, Lee P et al. Systolic function, readmission rates and survival among consecutively hospitalized patients with congestive heart failure. Am Heart J 1997; 134: 728-736.
28. Flather MD, Yusuf S, Kober L et al., for the ACE Inhibitor Myocardial Infarction Collaborative Group. Long term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: a systematic overview of data of individual patients. Lancet 2000; 355: 1575-1581.
29. Thien YT, Wang Y, Radford MJ, Krumholz HM. Angiotensin converting enzyme inhibitor dosage in elderly patients with heart failure. Am Heart J 2001; 141: 331-333.
30. McGrae McDermott M, Lee P, Metha S, Gherorghiade M. Patterns of angiotensin converting enzyme inhibitor prescriptions, additional interventions and outcomes among hospitalized patients with heart failure. Clin Cardiol 1998; 21: 261-268.
31. Packer M, Pool-Wilson PA, Amstrong PW et al., on behalf of the ATLAS study group. Comparative effect of low and high dose of angiotensin converting enzyme inhibitor, Lisinopril on morbidity and mortality in chronic heart failure. Circulation 1999; 100: 2312-2318.
32. Lussier AB, Forest A, Feuerstein SG, Schentag JJ, Izzo JR. Containment of heart failure hospitalizations and costs by angiotensin converting enzyme inhibitor dosage optimization. Am J Cardiol 2000; 86: 519-523.
33. Krumholz HM, Backers CD, Ashton CM et al. Evaluating quality of care for patients with heart failure. American Heart Association-American College of Cardiology Conference proceedings. Circulation 2000; 101: E122-E140.
34. Jencks SF, Cuerdon T, Burwend R et al. Quality of medical care delivered to medical beneficiaries. Profile estate and national levels. J Am Med Assoc 2000; 284: 1670-1676.
35. Ashton C, Del Junco D, Souchek J, Wray N, Mansyur C. The association between the quality of inpatient care and early readmissions: a meta analysis. Med Care 1997; 35: 1044-1059.
36. Kossovsky MP, Sarasin F, Perneger TV, Chopard P, Sigaud P, Gaspoz JM. Unplanned readmissions of patients with congestive heart failure: do they reflect in-hospital quality of care or patients characteristics? Am J Med 2000; 109: 386-390.